Literature DB >> 20492819

Congenital tufted angioma: Case report and review of the literature.

Fernando Toledo Alberola1, Isabel Betlloch, Laura Cuesta Montero, Irene Ballester Nortes, Nuria Latorre Martínez, Almudena Monteagudo Paz.   

Abstract

Tufted angiomas (TA) are rare benign vascular tumors of unknown pathogenesis. Most appear during childhood; approximately 25 percent are congenital and 50 percent appear in the first year of life. According to the literature, TA that are present at birth or in the first year of life have a greater tendency to spontaneously regress than do those that appear later in life. Their clinical presentation is non-specific and characterized by bluish-erythmatous plaques or nodules. The differential diagnosis includes infantile hemangiomas, congenital hemangiomas, kaposiform hemangioendothelioma and vascular malformations. Tufted angiomas have a characteristic histology consisting of a proliferation of endothelial cells forming lobules with the typical "shotgun" distribution. We report a case of congenital TA and review the cases of congenital TA described to date in the literature in order to highlight the different characteristics of congenital and acquired TA.

Entities:  

Mesh:

Year:  2010        PMID: 20492819

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  3 in total

1.  Tufted Angioma of Eyelid in an Adult - A Case Report.

Authors:  Jyoti Verma; Anshul Singh; Vatsala Misra; S P Singh
Journal:  J Clin Diagn Res       Date:  2016-06-01

2.  Tufted angioma in ear auricle: importance of the differential diagnosis.

Authors:  Carla Andréa Avelar Pires; Brena Andrade de Sousa; Gabriela Athayde Amin; Maraya de Jesus Semblano Bittencourt; Mario Fernando Ribeiro de Miranda; Francisca Regina Oliveira Carneiro
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

3.  Tufted angioma (Angioblastoma) of eyelid in adults-report of two cases.

Authors:  Ruchi Mittal; Devjyoti Tripathy
Journal:  Diagn Pathol       Date:  2013-09-17       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.